GFI1 and Miyoshi myopathy: Furthermore, in MM patients characterized by the gain of 1q21 (≤3 copies), GFI1-36N demonstrated a negative impact with a borderline statistical significance on OS and with significance on PFS (Log-rank: p= 0.052 and 0.008, respectively (Figures 1C, 2 and 3).